{"id":9082,"date":"2024-03-08T18:34:25","date_gmt":"2024-03-08T10:34:25","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9082"},"modified":"2024-03-19T11:24:08","modified_gmt":"2024-03-19T03:24:08","slug":"the-board-of-directors-approved-the-convening-of-the-2024-annual-shareholders-meeting","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/the-board-of-directors-approved-the-convening-of-the-2024-annual-shareholders-meeting\/","title":{"rendered":"The Board of Directors approved the convening of the 2024 Annual Shareholders’ Meeting."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2024\/03\/08<\/td>\nTime of announcement<\/td>\n18:34:36<\/td>\n<\/tr>\n
Subject<\/td>\n\n
The Board of Directors approved the convening of\r\nthe 2024 Annual Shareholders' Meeting.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2024\/03\/08<\/td>\nTo which item it meets<\/td>\nparagraph 17<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of the board of directors' resolution:2024\/03\/08\r\n2.Shareholders meeting date:2024\/06\/21\r\n3.Shareholders meeting location:No.631 Zhongzheng Road \r\n  Zhonghe District,New Taipei City \r\n  (RSL Hotel Taipei Zhonghe)\r\n4.Shareholders' meeting will be held by means of \r\n (physical shareholders' meeting\/ hybrid shareholders'\r\n  meeting \/virtual-only shareholders' meeting):\r\n  physical shareholders' meeting.\r\n5.Cause for convening the meeting (1)Reported matters:\r\n (1)2023 business report and 2024 business plan.\r\n (2)Audit Committee's review report on the 2023 \r\n    financial statements.\r\n (3)2023 distribution report of employee compensation \r\n    and director remuneration.\r\n (4)2023 distribution report of cash dividends.\r\n (5)Amending part of the articles of the Company's\r\n    \u201cRegulations Governing Procedure for Board of \r\n     Directors Meetings\u201c\r\n6.Cause for convening the meeting (2)Acknowledged \r\n  matters:\r\n (1)Adoption of 2023 financial statements.\r\n (2)Adoption of 2023 earnings distribution.\r\n7.Cause for convening the meeting (3)Matters for \r\n  Discussion:\r\n (1)Issuing new shares for capital increase by \r\n    earnings recapitalization.\r\n (2)Releasing the prohibition on directors from \r\n    participation in competition businesses.\r\n(3)Amending part of the articles of the Company's \r\n   \u201cProcedures for Election of Directors\u201d.\r\n(4)Amending part of the articles of the Company's \r\n   \u201cRules of Procedure for Shareholders\u2019 Meetings\u201d.\r\n8.Cause for convening the meeting (4)Election matters:\r\n  None.\r\n9.Cause for convening the meeting (5)Other Proposals:\r\n  None.\r\n10.Cause for convening the meeting (6)Extemporary \r\n   Motions: None.\r\n11.Book closure starting date:2024\/04\/23\r\n12.Book closure ending date:2024\/06\/21\r\n13.Any other matters that need to be specified:None.<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement 2024\/03\/08 Time of announcement 18:34:36 Subject The Board of Directors approved the convening of the 2024 Annual Shareholders’ Meeting. Date of events 2024\/03\/08 To which item it meets paragraph 17 Statement 1.Date of the board of directors’ resolution:2024\/03\/08 2.Shareholders meeting date:2024\/06\/21 3.Shareholders meeting location:No.631 Zhongzheng Road Zhonghe District,New Taipei …<\/p>\n
  The Board of Directors approved the convening of the 2024 Annual Shareholders’ Meeting.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9082","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9082","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9082"}],"version-history":[{"count":4,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9082\/revisions"}],"predecessor-version":[{"id":9086,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9082\/revisions\/9086"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9082"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9082"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9082"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}